Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. MSFT
6. NAVN
7. DFTX
8. CNC
9. KFY
10. SPY

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2019

Enanta Pharma (ENTA) Reports Q2 EPS of $0.20

May 7, 2019 4:01 PM EDT

Enanta Pharma (NASDAQ: ENTA) reported Q2 EPS of $0.20, versus $0.61 reported last year. Revenue for the quarter came in at $39.6 million versus the consensus estimate of $40.88 million.

Enanta remains in a strong financial position that allows us to continue to execute and advance our planned... More